Big Pharma Net Income Over Time
| PRM Stock | CAD 14.73 0.23 1.59% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Big Pharma Performance and Big Pharma Correlation. Big |
Cross Equities Net Income Analysis
Compare Big Pharma Split and related stocks such as Bankers Petroleum, Elysee Development Corp, and NMC Resource Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BNK | 5.3 M | 5.3 M | 5.3 M | 5.3 M | 5.3 M | 5.3 M | 5.3 M | 5.3 M | 5.3 M | 5.3 M | 5.3 M | 13.3 M | (4.1 M) | 2 M | 5 M | 4.5 M | 3.4 M |
| ELC | (403.9 K) | (2.5 M) | (3.5 M) | 673.1 K | 1.8 M | 744.3 K | 3.6 M | 651.4 K | 1.3 M | 1.8 M | 4 M | 37.7 K | (2.3 M) | (4 M) | 652.2 K | 750.1 K | 787.6 K |
| NRC | (63.1 K) | (63.1 K) | (63.1 K) | (63.1 K) | (63.1 K) | (63.1 K) | (63.1 K) | (63.1 K) | (63.1 K) | (63.1 K) | (63.1 K) | (63.1 K) | (246.2 K) | (1.3 M) | (28.5 M) | (25.7 M) | (24.4 M) |
| SATO | (24.9 K) | (24.9 K) | (24.9 K) | (24.9 K) | (24.9 K) | (24.9 K) | (24.9 K) | (24.9 K) | (10 K) | (43.5 K) | (36.7 K) | (1.7 M) | (8 M) | 776.5 K | 1.2 M | 1.1 M | 1.1 M |
| RE | (391.8 K) | (391.8 K) | (391.8 K) | (391.8 K) | (391.8 K) | (391.8 K) | (391.8 K) | (288.5 K) | (3.2 M) | (412.1 K) | (446.7 K) | (2.1 M) | (726.2 K) | (1.8 M) | (9.3 M) | (8.3 M) | (7.9 M) |
Big Pharma Split and related stocks such as Bankers Petroleum, Elysee Development Corp, and NMC Resource Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Big Pharma Split financial statement analysis. It represents the amount of money remaining after all of Big Pharma Split operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.My Equities
My Current Equities and Potential Positions
| Big Pharma Split | PRM |
Specialization | Financial Services, Financial Services |
| Business Address | 610 Chartwell Road, |
| Exchange | Toronto Exchange |
CAD 14.73
Other Information on Investing in Big Stock
Big Pharma financial ratios help investors to determine whether Big Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Big with respect to the benefits of owning Big Pharma security.